Demand for mental health care outstrips the supply of clinicians everywhere, and AI mental health startups are building into that gap from two directions: consumer tools people use directly, and infrastructure that makes clinicians more effective. NeuronFeed tracks 17 companies in this category with a combined $419M in funding.
On the consumer side, Youper ($5M raised) offers a clinically studied emotional health assistant built by a psychiatrist; Sonia ($3M) puts a voice-based AI therapist in your pocket, built by MIT and ETH researchers; and Rosebud ($6M) turns daily journaling into personalized mentorship. Tolan ($30M) takes the companion route with character-driven AI designed for friendship. The clinical wing is where recent funding has concentrated: Slingshot AI ($93M) is building a foundation model for mental health, Jimini Health ($25M) provides clinician-supervised AI infrastructure for behavioral health, Blossom Health ($20M) runs an AI operating system for psychiatry, and Kintsugi ($28M) detects depression and anxiety signals from voice biomarkers.
The technology ranges from LLM-driven conversation grounded in CBT-style techniques to specialized models analyzing speech patterns. What separates leaders is clinical rigor: published studies, clinician supervision, crisis-escalation protocols that hand off to humans, and honest boundaries about what the product is not — most position as support and skills practice, not therapy replacement.
Anyone evaluating tools here should check for evidence of clinical validation, clear crisis handling (what happens when a user expresses self-harm risk), data privacy far beyond standard app norms, and regulatory posture — the line between wellness app and medical device is tightening in both the US and EU.